跳至主要内容
临床试验/NL-OMON55138
NL-OMON55138已完成不适用

IXSI: Interventional X-ray and Scintigraphy Imaging of 99mTc-MAA during the radioembolisation pretreatment procedure - IXSI

niversitair Medisch Centrum Utrecht0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Participants must have given written informed consent and comply
  • with the requirements of the study protocol.
  • 2. Must be aged 18 years or over.
  • 3. Must be selected to undergo a 99mTc-MAA procedure as part of their
  • radioembolisation treatment.
  • 4. Sufficiently fit to undergo an additional examination time of
  • 30-90 minutes.
  • 5. Have a CT acquired less than 6 weeks before the pre-treatment
  • radioembolisation procedure.

排除标准

  • 1. Patients expected to require more than two injection positions for
  • radioembolisation treatment.
  • 2. Pregnancy or nursing.
  • 3. Patients suffering from psychic disorders that make a comprehensive
  • judgement impossible, such as psychosis, hallucinations and/or depression.
  • 4. Patients who are declared incompetent.
  • 5. Previous enrollment in the present study
  • 6. Claustrophobia
  • 7. The last dose of prior chemotherapy has been received less than 4 weeks
  • prior to the planned 99mTc-MAA pretreatment procedure.
  • 8. Radiation therapy within the last 4 weeks before the planned 99mTc-MAA
  • pretreatment procedure
  • 9. Major surgery within the last 4 weeks prior to the planned 99mTc-MAA
  • pretreatment procedure
  • 10. Any unresolved toxicity greater than Common Terminology Criteria for
  • Adverse Events (CTCAE version 5 , see appendix 1) grade 2 from previous
  • anti-cancer treatment
  • 11. Body weight over 250 kg (because of maximum table load)
  • 12. Patient length over 1.90 m (to fit IXSI geometry)
  • 13. Patient bust line over 135 cm (to fit IXSI geometry)

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验